prolaio eVO2peak Module vs uOmnispace.MR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Prolaio
VS
by Shanghai United Imaging Healthcare Co., Ltd.

AI Verdict

Tool A specializes in estimating peak oxygen consumption (eVO2peak) using data from wearable sensors for cardiovascular evaluation, focusing on functional capacity. Tool B, on the other hand, provides comprehensive AI-powered analysis of magnetic resonance (MR) images for enhanced diagnostics across various specialties, including detailed cardiac structural and functional assessment. While both contribute to cardiology, they address different diagnostic needs and utilize distinct data modalities.

Choose prolaio eVO2peak Module if…

Choose Prolaio eVO2peak Module if your primary need is to longitudinally estimate peak oxygen consumption (eVO2peak) for cardiovascular risk assessment or research, leveraging real-world data from qualified third-party wearable sensors. This tool is ideal for integrating continuous, non-invasive physiological insights as an adjunctive aid in clinical evaluation.

View prolaio eVO2peak Module →

Choose uOmnispace.MR if…

Choose uOmnispace.MR if your focus is on advanced, AI-powered analysis and post-processing of magnetic resonance (MR) images across various clinical applications, including detailed cardiac function, brain perfusion, or oncological assessments. This software is best suited for radiologists and specialists requiring comprehensive diagnostic interpretation from MR scans.

View uOmnispace.MR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature prolaio eVO2peak Module uOmnispace.MR
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based (software-only, processes remote sensor data) Software-only medical device; can run standalone or integrated with other cleared applications on standard off-the-shelf PCs; supports remote multi-user access on a network. The broader uOmnispace platform is available as SaaS, on-premise, or hybrid.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

prolaio eVO2peak Module

Tool A, Prolaio eVO2peak Module, focuses on patient-centric remote monitoring using wearables and a mobile app, which suggests a simpler and more intuitive user experience for patients and care teams managing continuous data. Prolaio emphasizes user research to inform design decisions and streamline clinical workflows.

Clinical Value

uOmnispace.MR

Tool B, uOmnispace.MR, offers comprehensive AI-powered MR image analysis across a broader range of clinical applications, including brain, breast, and cardiac imaging, with advanced post-processing tools like spectroscopy and perfusion analysis. This provides wider diagnostic capabilities and greater overall clinical utility for a hospital or radiology department compared to Tool A's specialized focus on eVO2peak estimation.

Pricing & Value

uOmnispace.MR

Both tools require direct contact for pricing, making transparency equal. However, uOmnispace.MR is part of a broader uOmnispace platform that supports multiple imaging modalities (PET, CT, MR, SPECT), suggesting a higher potential for integrated workflows and broader utility within a healthcare institution, thus likely providing greater overall value for the investment.

Enterprise Readiness

uOmnispace.MR

Both tools are highly enterprise-ready with FDA clearance, HIPAA compliance, and BAAs. However, Tool B offers more flexible deployment options (standalone, integrated, SaaS, on-premise, hybrid) and explicit support for remote multi-user access, which caters to a wider range of institutional IT infrastructures and preferences, making it slightly more adaptable for large-scale enterprise integration.

Innovation

prolaio eVO2peak Module

Tool A's innovation lies in its unique approach to estimating peak oxygen consumption (eVO2peak) by leveraging real-world data from FDA-cleared wearable medical sensors and a deep-learning model. This provides a novel, non-invasive method for continuous cardiovascular assessment.

Support & Docs

Tie

Both companies demonstrate a commitment to support. Prolaio highlights 'always-on support' and direct contact channels for its patient-centric monitoring. United Imaging Healthcare offers a comprehensive 'Online Document Library,' 24/7 remote monitoring, and dedicated training for its complex imaging software. Without more specific details on service level agreements or user satisfaction, it is difficult to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature prolaio eVO2peak Module uOmnispace.MR
Product Name prolaio eVO2peak Module uOmnispace.MR
Company Prolaio Shanghai United Imaging Healthcare Co., Ltd.
Primary Purpose Estimates peak oxygen consumption using real-world patient data for cardiovascular research and care. AI-powered software for comprehensive magnetic resonance (MR) image analysis, supporting diverse clinical applications.
Primary Categories Cardiology AI, Clinical Decision Support & Reference Cardiology AI, Neurology AI, Oncology AI
Supported Specialties Cardiology, Physical Medicine & Rehab, Sports Medicine Cardiology, Neurology, Radiology
Core Functionality Estimates peak oxygen consumption (eVO2peak), utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs, processes data from qualified third-party FDA-cleared wearable medical sensors, applies a locked deep-learning model. MR image viewing, processing, and analysis, AI-driven cardiac ventricular segmentation, stitching for full-format MR images, dynamic studies analysis, MR Spectroscopy (SVS and CSI), Perfusion analysis (e.g., Brain Perfusion), Vessel analysis for MR vascular images, Cardiac function analysis.

Videos

Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and uOmnispace.MR.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Prolaio eVO2peak Module is designed to estimate peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care, serving as an adjunctive aid in clinical evaluation. In contrast, uOmnispace.MR is an AI-powered software for comprehensive magnetic resonance (MR) image analysis, supporting diverse clinical applications including brain, breast, and cardiac imaging with advanced post-processing tools and AI-driven segmentation.
The Prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors. uOmnispace.MR primarily processes magnetic resonance (MR) images for its analysis.
The Prolaio eVO2peak Module supports Cardiology, Physical Medicine & Rehab, and Sports Medicine. uOmnispace.MR supports Cardiology, Neurology, and Radiology.
The Prolaio eVO2peak Module estimates eVO2peak using a locked deep-learning model and proprietary algorithms, enabling high-density, longitudinal data collection from real-world patient data. uOmnispace.MR offers MR image viewing, processing, and analysis, including AI-driven cardiac ventricular segmentation, stitching for full-format MR images, dynamic studies analysis, MR Spectroscopy (SVS and CSI), perfusion analysis (e.g., Brain Perfusion), and vessel analysis for MR vascular images.
The Prolaio eVO2peak Module requires data from qualified third-party FDA-cleared wearable medical sensors. uOmnispace.MR is a software-only medical device that can run on standard off-the-shelf PCs and processes MR images, which are typically acquired from MRI scanners.
AI Tool Finder
AI-powered search. Results may not be comprehensive.